J Damås

1.5k total citations
24 papers, 1.2k citations indexed

About

J Damås is a scholar working on Immunology, Oncology and Immunology and Allergy. According to data from OpenAlex, J Damås has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 4 papers in Immunology and Allergy. Recurrent topics in J Damås's work include Chemokine receptors and signaling (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Immune Response and Inflammation (4 papers). J Damås is often cited by papers focused on Chemokine receptors and signaling (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Immune Response and Inflammation (4 papers). J Damås collaborates with scholars based in Norway, United States and Croatia. J Damås's co-authors include Pål Aukrust, Thor Ueland, Camilla Smith, Kari Otterdal, Stig S. Frøland, Pål Aukrust, Arne Yndestad, Tom Eirik Mollnes, Nils Olav Solum and Wiggo J. Sandberg and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

J Damås

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Damås Norway	17	446	315	308	264	243	24	1.2k
Lauren Clancy United States	8	337 0.8×	148 0.5×	238 0.8×	112 0.4×	370 1.5×	13	1.2k
Richard W. Kim United States	14	203 0.5×	242 0.8×	246 0.8×	328 1.2×	579 2.4×	25	1.6k
Patrik Stolt Sweden	5	399 0.9×	116 0.4×	123 0.4×	284 1.1×	146 0.6×	5	1.9k
Majd Mouded United States	9	757 1.7×	58 0.2×	320 1.0×	394 1.5×	295 1.2×	13	1.5k
Monica Attanasio Italy	20	155 0.3×	391 1.2×	104 0.3×	215 0.8×	155 0.6×	44	1.1k
Toshihiko Hidaka Japan	21	439 1.0×	77 0.2×	90 0.3×	151 0.6×	181 0.7×	79	1.4k
Amy Gallo United States	14	434 1.0×	504 1.6×	126 0.4×	778 2.9×	247 1.0×	44	1.6k
Julia Barbara Kral Austria	12	325 0.7×	119 0.4×	157 0.5×	107 0.4×	206 0.8×	18	868
J. Herbert United Kingdom	6	483 1.1×	140 0.4×	116 0.4×	68 0.3×	280 1.2×	10	1.0k
P C Comp United States	16	232 0.5×	341 1.1×	65 0.2×	164 0.6×	166 0.7×	24	1.8k

Countries citing papers authored by J Damås

Since Specialization

Citations

This map shows the geographic impact of J Damås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Damås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Damås more than expected).

Fields of papers citing papers by J Damås

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Damås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Damås. The network helps show where J Damås may publish in the future.

Co-authorship network of co-authors of J Damås

This figure shows the co-authorship network connecting the top 25 collaborators of J Damås. A scholar is included among the top collaborators of J Damås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Damås. J Damås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Østvik, Ann Elisabet, Nadra Nilsen, Atle van Beelen Granlund, et al.. (2012). P057 Enhanced expression of CXCL10 in inflammatory bowel disease potential role of mucosal Toll-like receptor 3 stimulation. Journal of Crohn s and Colitis. 6. S33–S33. 1 indexed citations

Breland, Unni M., Ivana Hollan, Kjell Saatvedt, et al.. (2010). Inflammatory markers in patients with coronary artery disease with and without inflammatory rheumatic disease. Lara D. Veeken. 49(6). 1118–1127. 23 indexed citations

Eagan, Tomas, Thor Ueland, Peter D. Wagner, et al.. (2009). Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. European Respiratory Journal. 35(3). 540–548. 169 indexed citations

Halvorsen, Bente, Thor Ueland, Camilla Smith, et al.. (2009). Treatment with the PPARγ agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome. European Journal of Endocrinology. 162(2). 267–273. 16 indexed citations

Smith, Camilla, Bente Halvorsen, Kari Otterdal, et al.. (2008). High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. Cardiovascular Research. 79(1). 195–203. 46 indexed citations

Aukrust, Pål, Kari Otterdal, Arne Yndestad, et al.. (2008). The complex role of T-cell-based immunity in atherosclerosis. Current Atherosclerosis Reports. 10(3). 236–243. 22 indexed citations

Ueland, Thor, Pål Aukrust, Arne Yndestad, et al.. (2005). Soluble CD40 ligand in acute and chronic heart failure. European Heart Journal. 26(11). 1101–1107. 61 indexed citations

Damås, J, Agnès Boullier, Torgun Wæhre, et al.. (2005). Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy. Arteriosclerosis Thrombosis and Vascular Biology. 25(12). 2567–2572. 108 indexed citations

Wæhre, Torgun, J Damås, Arne Yndestad, et al.. (2004). Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells – potential role of prostaglandin E2. Thrombosis and Haemostasis. 92(12). 1358–1367. 22 indexed citations

10.

Damås, J, Kari Otterdal, Halfdan Aass, et al.. (2004). 1123-187 Soluble CD40 ligand in pulmonary arterial hypertension: Possible pathogenic role of interaction between platelets and endothelial cells. Journal of the American College of Cardiology. 43(5). A503–A503.

11.

Hognestad, Aina, Annika E. Michelsen, Frank Brosstad, et al.. (2004). Platelet activation in heart transplant recipients. Clinical Transplantation. 18(2). 142–147. 22 indexed citations

12.

Damås, J, Kari Otterdal, Arne Yndestad, et al.. (2004). Soluble CD40 Ligand in Pulmonary Arterial Hypertension. Circulation. 110(8). 999–1005. 83 indexed citations

13.

Holm, T., J Damås, Kirsten B. Holven, et al.. (2003). CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells. Journal of Thrombosis and Haemostasis. 1(2). 257–262. 35 indexed citations

14.

Damås, J, Pål Aukrust, Thor Ueland, et al.. (2001). Monocyte chemoattractant protein-1 enhances and interleukin-10 suppresses the production of inflammatory cytokines in adult rat cardiomyocytes. Basic Research in Cardiology. 96(4). 345–352. 36 indexed citations

15.

Damås, J. (2000). CXC-chemokines, a new group of cytokines in congestive heart failure — possible role of platelets and monocytes. Cardiovascular Research. 45(2). 428–436. 123 indexed citations

16.

Damås, J. (2000). Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovascular Research. 47(4). 778–787. 180 indexed citations

17.

Damås, J, et al.. (1982). [Platelets, lysosomal enzymes and anaphylactic shock in the rat].. PubMed. 176(4). 553–7. 1 indexed citations

18.

Damås, J, et al.. (1980). Leucocytes-prostaglandins and carregeenans.. PubMed. 246(1). 167–9. 2 indexed citations

19.

Damås, J. (1978). [Hypotensive action of arachidonic acid, slow acting analphylactic substance (SRS-A) and thromboxane A2 in rats].. PubMed. 172(5). 1025–8. 1 indexed citations

20.

Deby, C., et al.. (1975). [An in vivo test for prostaglandin synthesis].. PubMed. 130(2-3). 178–93.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact